Intraoperative Local Infusion Chemotherapy for Advanced Gastric Cancer

  • Keijiro Araki
  • Takashi Beppu
  • Hiraku Yamamoto
  • Michiya Kobayashi
  • Kimio Matsuura


Recently the treatment results of gastric carcinoma has improved because of the increase of early gastric cancer, however, the mortality is still high among patients with advanced disease even those in whom radical resection is possible. Radical surgery with lymph nodes dissection is still the mainstay of therapy [1]. On the other hand, metastases were high frequently found in the distant lymph nodes, such as paraaortic lymph nodes [2]. In view of the numerous possible pathways of lymphatic drainage from the stomach, complete dissection of these lymph nodes is virtually impossible. Locoregional recurrence represents a major pattern of surgical failure in patients who have undergone anticipated curative resection [3,4].


Gastric Cancer Gastric Cancer Patient Paraaortic Lymph Node Platinum Concentration Advanced Gastric Cancer Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Okajima K (1977) Surgical treatment of gastric cancer with special reference to lymph node removal. Acta Med Okayama 31:369–382PubMedGoogle Scholar
  2. 2.
    Nashimoto A, Sasaki J, Akai S (1991) The study of lymphatic routes to the abdominal para-aortic lymph nodes and the significance of these lymph node dissection for advanced gastric cancer (in Japanese). (Jpn J Gastroenterol Surg Nihon Syoukakigekagakkaisi) 24:1169–1178CrossRefGoogle Scholar
  3. 3.
    Wisbeck WM, Becher EM, Russel AH (1986) Adenocarcinoma of the stomach: autopsy observations with therapeutic implications for the radiation oncologist. Radiother Oncol 7:13–18PubMedCrossRefGoogle Scholar
  4. 4.
    Papachristou DN, Fortner JG (1981) Local recurrence of gastric adenocarcinoma after gastrectomy. J Surg Oncol 18:47–53PubMedCrossRefGoogle Scholar
  5. 5.
    Ajani JA, Ota DM, Jessup JM, et al (1974) Resectable gastric carcinoma: an evaluation of preoperative and postoperative chemotherapy. Cancer 68:1501–1506CrossRefGoogle Scholar
  6. 6.
    Abe M, Yabumoto E, Takahashi M, Tobe T, Mori K (1974) Intraoperative radiotherapy of gastric cancer. Cancer 34:2034–2041PubMedCrossRefGoogle Scholar
  7. 7.
    Ogata T, Araki K, Matuura K, Kobayashi M, Inomata T, Yasuhiko O, Yosida S (1995) A ten-year experience of intraoperative radiotherapy for gastric carcinoma and a new surgical method of creating a wider irradiation field for cases of total gastrectomy patients. Int J Radiat Oncol Biol Phys 32:341–347PubMedCrossRefGoogle Scholar
  8. 8.
    Nakajima T, Fukami A, Takagi K, Kajitani T (1980) Adjuvant chemotherapy with mitomycin C, and with a multidrug combination of mitomycin C, 5-fluorouracil and cytosine arabinoside after curative resection of gastric cancer. Jpn J Clin Oncol 10:187–194Google Scholar
  9. 9.
    Leichman L, Berry BT (1991) Cisplatin therapy for adenocarcinoma of the stomach. Semin Oncol 18(suppl 3):25–33PubMedGoogle Scholar
  10. 10.
    Gehan EA, Freireich EJ (1974) Non-randomized controls in cancer clinical trials. N Engl J Med 24:198–203CrossRefGoogle Scholar
  11. 11.
    Bodey GP, Gehan EA, Freireich EJ, Frei E III (1971) Protected environment: prophylactic antibiotic program in the chemotherapy of acute leukemia. Am J Med Sci 262:138–151PubMedCrossRefGoogle Scholar
  12. 12.
    Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457–481CrossRefGoogle Scholar
  13. 13.
    Gehan EA (1965) A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203–223PubMedGoogle Scholar
  14. 14.
    Gunderson LL, Sosin H (1981) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1–11CrossRefGoogle Scholar
  15. 15.
    Stephens FO (1983) Pharmacokinetics of intra-arterial chemotherapy. Recent Results Cancer Res 86:1–12PubMedCrossRefGoogle Scholar
  16. 16.
    Shimoyama M, Kimura K, Culture of human cancer cell line, in Oboshi S, Sugano H, eds (1975) kagaku-ryoho (Chemotherapy) (in Japanese). Tokyo: Asakura; pp 477–499Google Scholar
  17. 17.
    Takahashi K, Ebihara K, Honda Y, Nishikawa K, Kita M, Oomura M, et al (1982) Antitumor activity of cisdichlorodiammineplatinum (II) and its effect on cell cycle progression (in Japanese) Gan to Kagaku-ryoho (Jpn J Cancer Chemother) 9:624–631Google Scholar
  18. 18.
    Sugiyama Y, Kobayashi T, Inaba M (1987) Quantitative analysis of cell-kill effects of anticancer drugs: Consideration of both in in vitro and in vivo experimental system, (in Japanese with English abstract) Gan-to-kagaku-ryoho (Jpn J Cancer Chemother) 14:3183–3198Google Scholar
  19. 19.
    Yamamoto H, Ogata T, Araki K (1996) Intraoperative local infusion chemotherapy (ILIC) for VX2 cancer (in Japanese with English abstract) Nihon Gantiryogakkaisi (J Jpn Soc Cancer Ther) 31:143–151Google Scholar
  20. 20.
    Litterest CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM (1976) Distribution and disposition of platinum following intravenous administration of cisdiamminedichloropla-tinum (II) to dogs. Cancer Res 36:2340–2344Google Scholar
  21. 21.
    Gullo JJ, Litterst CL, Maguire PJ, Sikic BI, Hoth DF, Woolley PV (1980) Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion. Cancer Chemother Pharmacol 5:21–26PubMedCrossRefGoogle Scholar
  22. 22.
    Wolpert-DeFillippes MK (1979) Antitumor activity of cisdichlorodiammine-platinum (II). Cancer Treat Rep 63:1453–1458Google Scholar
  23. 23.
    Tateyama I, Hashii K, Natsuyama S, Kanto T, Tominaga T, Kamitani N, Mori T (1989) Experimental local administration of CDDP to in vitro models of gynecological malignant tumors transplanted into nude mice: compared with medroxyprogesterone acetate orally administrated. Nihon Gantiryogakkaisi J Jpn Soc Cancer Ther 24:1053–1066Google Scholar
  24. 24.
    Maruyama K (1987) The most important prognostic factors for gastric cancer patients: a study using univariate and multivariate analysis. Scand Gastroenterol 22(Suppl 133):63–68CrossRefGoogle Scholar
  25. 25.
    Curtis RE, Kennedy BJ, Myers MH, Hankey BF (1985) Evaluation of AJC stomach cancer staging using the SEER population. Semin Oncol 12:21–31PubMedGoogle Scholar
  26. 26.
    Goto M, Matsubara Y, Nakazato H, Kato K, Asano C (1979) Statistical evaluation of factors influencing prognosis of gastric cancer patients: prediction of prognosis on patient clusters. Environ Health Perspect 32:102–112Google Scholar

Copyright information

© Springer Japan 1999

Authors and Affiliations

  • Keijiro Araki
    • 1
  • Takashi Beppu
    • 1
  • Hiraku Yamamoto
    • 1
  • Michiya Kobayashi
    • 1
  • Kimio Matsuura
    • 1
  1. 1.First Department of SurgeryKochi Medical SchoolKochiJapan

Personalised recommendations